FreeTheAI

Rocket Pharmaceuticals, Inc.

RCKT · NASDAQ · USD

$2.63

+0.095 3.75%todayNot financial advice.

RCKT Price chart 6M
Open
2.78
Day range
2.52 - 2.78
52-week range
2.42 - 5.45
Volume
3.46M
Market cap
288.71M
P/E ratio
—
EPS
-0.16
Dividend yield
0.00%
Beta
2.35

Performance

W

+0.38%

1M

−30.42%

3M

−36.93%

6M

−26.74%

YTD

−25.07%

Y

−17.03%

5Y

−91.01%

All

−89.22%

In the news

  1. Oct 8

    Rocket Pharmaceuticals Upgraded by Goldman Sachs on Danon Disease Therapy Progress

    Rocket Pharmaceuticals was upgraded to Neutral by Goldman Sachs following clinical and regulatory updates for its Danon disease gene therapy.

    Analyst ratings

  2. Oct 7

    Rocket Pharmaceuticals Agrees with FDA on Trial Path for Danon Disease Therapy

    Rocket Pharmaceuticals mapped out an FDA-aligned path to complete its pivotal Phase 2 trial of RP-A501, showing sustained activity in earlier tests.

    Company news

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/NASDAQ-RCKT" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Rocket Pharmaceuticals, Inc. (RCKT) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-RCKT">RCKT stock price</a> by FreeTheAI Stocks</p>